Abnormalities of the inactive X chromosome are a common feature of brca1 mutant and sporadic basal-like breast cancer

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 93-97

  Ganesan, S ^a,c   Richardson, A L ^a   Wang, Z C ^a   Iglehart, J D ^a   Miron, A ^a   Feunteun, J ^b   Silver, D ^a   Livingston, D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; PROTEIN P53; SEX HORMONE; BRCA1 PROTEIN; COMPLEMENTARY DNA; CYTOKERATIN 14;

BREAST CANCER; CANCER STAGING; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONFERENCE PAPER; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; X CHROMOSOME; ARTICLE; CELL CYCLE PARAMETERS; CELL PROLIFERATION; DNA DAMAGE; IMMUNOHISTOCHEMISTRY; WILD TYPE; X CHROMOSOME ABERRATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HETEROCHROMATIN; HUMANS; NEOPLASMS, BASAL CELL; X CHROMOSOME INACTIVATION;

EID: 33746468064     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.045     Document Type: Conference Paper

References (19)

1. Chadwick B.P. and Lane T.F. 2005. BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation. Chromosoma 114: 432.
2. Foulkes W.D., Stefansson I.M., Chappuis P.O., Begin L.R., Goffin J.R., Wong N., Trudel M., and Akslen L.A. 2003. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J. Natl. Cancer Inst. 95: 1482.
3. Foulkes W.D., Brunet J.S., Stefansson I.M., Straume O., Chappuis P.O., Begin L.R., Hamel N., Goffin J.R., Wong N., Trudel M., Kapusta L., Porter P., and Akslen L.A. 2004. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer. Res. 64: 830.
4. Ganesan S., Silver D.P., Greenberg R.A., Avni D., Drapkin R., Miron A., Mok S.C., Randrianarison V., Brodie S., Salstrom J., Rasmussen T.P., Klimke A., Marrese C., Marahrens Y., Deng C.X., Feunteun J., and Livingston D.M. 2002. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111: 393.
5. Laakso M., Loman N., Borg A., and Isola J. 2005. Cytokeratin 5/14-positive breast cancer: True basal phenotype confined to BRCA1 tumors. Mod. Pathol 18: 1321.
6. Lakhani S.R., Gusterson B.A., Jacquemier J., Sloane J.P., Anderson T.J., van de Vijver M.J., Venter D., Freeman A., Antoniou A., McGuffog L., Smyth E., Steel C.M., Haites N., Scott R.J., Goldgar D., Neuhausen S., Daly P.A., Ormiston W., McManus R., Scherneck S., Ponder B.A., Futreal P.A., Peto J., Stoppa-Lyonnet D., Bignon Y.J., and Stratton M.R. 2000. The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin. Cancer Res. 6: 782.
7. Lakhani S.R., Reis-Filho J.S., Fulford L., Penault-Llorca F., van der Vijver M., Parry S., Bishop T., Benitez J., Rivas C., Bignon Y.J., Chang-Claude J., Hamann U., Cornelisse C.J., Devilee P., Beckmann M.W., Nestle-Kramling C., Daly P.A., Haites N., Varley J., Lalloo F., Evans G., Maugard C., Meijers-Heijboer H., Klijn J.G., Olah E., Gusterson B.A., Pilotti S., Radice P., Scherneck S., Sobol H., Jacquemier J., Wagner T., Peto J., Stratton M.R., McGuffog L., and Easton D.F. 2005. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin. Cancer Res. 11: 5175.
8. Narod S.A. and Foulkes W.D. 2004. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer 4: 665.
9. Palacios J., Honrado E., Osorio A., Cazorla A., Sarrio D., Barroso A., Rodriguez S., Cigudosa J.C., Diez O., Alonso C., Lerma E., Dopazo J., Rivas C., and Benitez J. 2005. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res. Treat. 90: 5.
10. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A.F., O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen Dale A.L., Brown P.O., and Botstein D. 2000. Molecular portraits of human breast tumours. Nature 406: 747.
11. Richardson A.L., Wang Z.C., De Nicolo A., Lu X., Brown M., Miron A., Liao X., Iglehart J.D., Livingston D.M., and Ganesan S. 2006. X chromosomal abnormalities in basal-like, human breast cancer. Cancer Cell 9: 121.
12. Scully R., Xie A., and Nagaraju G. 2004. Molecular functions of BRCA1 in the DNA damage response. Cancer Biol. Ther. 3: 521.
13. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., Demeter J., Perou C.M., Lonning P.E., Brown P.O., Borresen-Dale A.L., and Botstein D. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. 100: 8418.
14. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein Lonning P., and Borresen-Dale A.L. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. 98: 10869.
15. Turner J.M., Aprelikova O., Xu X., Wang R., Kim S., Chandramouli G.V.R., Barrett J.C., Burgoyne P.S., and Deng C.X. 2004. BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation. Curr. Biol. 14: 2135.
16. Turner N., Tutt A., and Ashworth A. 2004. Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer 4: 814.
17. Venkitaraman A.R. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171.
18. _. 2003. A growing network of cancer-susceptibility genes. N. Engl. J. Med. 348: 1917.
19. Wang Z.C., Lin M., Wei L.J., Li C., Miron A., Lodeiro G., Harris L., Ramaswamy S., Tanenbaum D.M., Meyerson M., Iglehart J.D., and Richardson A. 2004. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res. 64: 64.